A detailed history of Jpmorgan Chase & CO transactions in Atri Cure, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 325,147 shares of ATRC stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
325,147
Previous 471,012 30.97%
Holding current value
$10.9 Million
Previous $14.3 Million 48.33%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$19.86 - $29.09 $2.9 Million - $4.24 Million
-145,865 Reduced 30.97%
325,147 $7.4 Million
Q1 2024

May 10, 2024

BUY
$28.21 - $37.78 $3.24 Million - $4.34 Million
114,779 Added 32.22%
471,012 $14.3 Million
Q4 2023

Feb 12, 2024

BUY
$32.99 - $43.25 $1.13 Million - $1.48 Million
34,223 Added 10.63%
356,233 $12.7 Million
Q3 2023

Nov 14, 2023

SELL
$41.12 - $57.73 $862,574 - $1.21 Million
-20,977 Reduced 6.12%
322,010 $14.1 Million
Q2 2023

Aug 11, 2023

BUY
$40.44 - $49.6 $10.9 Million - $13.4 Million
269,454 Added 366.44%
342,987 $16.9 Million
Q1 2023

May 18, 2023

BUY
$35.87 - $47.22 $2.07 Million - $2.72 Million
57,701 Added 364.46%
73,533 $3.05 Million
Q1 2023

May 11, 2023

SELL
$35.87 - $47.22 $1.62 Million - $2.13 Million
-45,049 Reduced 74.0%
15,832 $656,000
Q4 2022

Feb 13, 2023

BUY
$33.48 - $47.45 $208,948 - $296,135
6,241 Added 11.42%
60,881 $2.7 Million
Q3 2022

Nov 14, 2022

BUY
$38.25 - $52.62 $121,596 - $167,278
3,179 Added 6.18%
54,640 $2.14 Million
Q2 2022

Aug 11, 2022

BUY
$35.1 - $66.01 $368,339 - $692,708
10,494 Added 25.62%
51,461 $2.1 Million
Q1 2022

May 11, 2022

SELL
$57.43 - $71.39 $1.28 Million - $1.59 Million
-22,323 Reduced 35.27%
40,967 $2.69 Million
Q4 2021

Feb 10, 2022

BUY
$63.4 - $87.14 $1.94 Million - $2.66 Million
30,576 Added 93.46%
63,290 $4.4 Million
Q3 2021

Nov 12, 2021

BUY
$69.28 - $84.46 $2.27 Million - $2.76 Million
32,714 New
32,714 $2.28 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.56B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.